These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 34625387)

  • 1. Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer.
    Rao Malla R; Marni R; Kumari S; Chakraborty A; Lalitha P
    Clin Breast Cancer; 2022 Apr; 22(3):200-211. PubMed ID: 34625387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Metabolites and Breast Cancer: The Continuum of Dysbiosis, Breast Cancer Risk, and Potential Breast Cancer Therapy.
    Jaye K; Chang D; Li CG; Bhuyan DJ
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of microbiome dysbiosis on T cell function within the tumor microenvironment (TME).
    DiPalma MP; Blattman JN
    Front Cell Dev Biol; 2023; 11():1141215. PubMed ID: 37009485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Gut Microbiota Dysbiosis in Breast Cancer and Novel Approaches in Prevention, Diagnosis, and Treatment.
    Ruo SW; Alkayyali T; Win M; Tara A; Joseph C; Kannan A; Srivastava K; Ochuba O; Sandhu JK; Went TR; Sultan W; Kantamaneni K; Poudel S
    Cureus; 2021 Aug; 13(8):e17472. PubMed ID: 34513524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
    Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
    Front Immunol; 2020; 11():612202. PubMed ID: 33488618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer.
    Parida S; Sharma D
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):392-405. PubMed ID: 30981803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbiosis of lower respiratory tract microbiome are associated with proinflammatory states in non-small cell lung cancer patients.
    Li Y; Rao G; Zhu G; Cheng C; Yuan L; Li C; Gao J; Tang J; Wang Z; Li W
    Thorac Cancer; 2024 Jan; 15(2):111-121. PubMed ID: 38041547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Tumor Microenvironment: Emerging target of therapeutic phytochemicals.
    Malla RR; Deepak K; Merchant N; Dasari VR
    Phytomedicine; 2020 Apr; 70():153227. PubMed ID: 32339885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-Microbiome Interaction in Lung Cancer.
    Dong Q; Chen ES; Zhao C; Jin C
    Front Immunol; 2021; 12():679829. PubMed ID: 34108973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The possible mechanisms of the human microbiome in allergic diseases.
    Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral Microbiome: Foe or Friend in Reshaping the Tumor Microenvironment Landscape?
    Kyriazi AA; Karaglani M; Agelaki S; Baritaki S
    Cells; 2024 Jul; 13(15):. PubMed ID: 39120310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of the Microbiome on Immunotherapy for Gastroesophageal Cancer.
    Dadgar N; Edlukudige Keshava V; Raj MS; Wagner PL
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Microbiome as a Component of the Tumor Microenvironment.
    Kovács T; Mikó E; Ujlaki G; Sári Z; Bai P
    Adv Exp Med Biol; 2020; 1225():137-153. PubMed ID: 32030653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiome as a biomarker and therapeutic target in pancreatic cancer.
    Pourali G; Kazemi D; Chadeganipour AS; Arastonejad M; Kashani SN; Pourali R; Maftooh M; Akbarzade H; Fiuji H; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Khazaei M; Avan A
    BMC Microbiol; 2024 Jan; 24(1):16. PubMed ID: 38183010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy.
    Han ZJ; Li YB; Yang LX; Cheng HJ; Liu X; Chen H
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Lactobacillus contribute to the progression of breast cancer by affecting the anti-tumor activities of immune cells in the TME of tumor-bearing mice.
    Shi Q; Wang J; Zhou M; Zheng R; Zhang X; Liu B
    Int Immunopharmacol; 2023 Nov; 124(Pt B):111039. PubMed ID: 37862739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the human microbiome - A step forward for precision medicine in breast cancer.
    Jotshi A; Sukla KK; Haque MM; Bose C; Varma B; Koppiker CB; Joshi S; Mishra R
    Cancer Rep (Hoboken); 2023 Nov; 6(11):e1877. PubMed ID: 37539732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T Cells and Plasmacytoid Dendritic Cells Within the Tumor Microenvironment in Gastric Cancer Are Correlated With Gastric Microbiota Dysbiosis: A Preliminary Study.
    Ling Z; Shao L; Liu X; Cheng Y; Yan C; Mei Y; Ji F; Liu X
    Front Immunol; 2019; 10():533. PubMed ID: 30936882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer.
    Deepak KGK; Vempati R; Nagaraju GP; Dasari VR; S N; Rao DN; Malla RR
    Pharmacol Res; 2020 Mar; 153():104683. PubMed ID: 32050092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural products: Potential targets of TME related long non-coding RNAs in lung cancer.
    Malla RR; Padmaraju V; Marni R; Kamal MA
    Phytomedicine; 2021 Dec; 93():153782. PubMed ID: 34627097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.